Preliminary scientific tests suggest conolidine may well inhibit specific ion channels, lowering neuronal excitability and limiting agony signals. This mechanism is especially pertinent in neuropathic agony, wherever abnormal signaling triggers persistent soreness. In addition, conolidine seems to influence G protein-coupled receptor (GPCR) pathway